Navigation Links
BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets

Madison, WI (PRWEB) July 14, 2013

Join us for a webinar on July 17, 2013 at 12:00 PM EDT:

Tools for Screening Chromatin Modifying Enzymes

Register now:

Biochemical HTS assays are a critical component of drug discovery programs focused on epigenetic drug targets like methyltransferases, acetyltransferases or kinases. Assembling high quality assay reagents and validating them on a detection platform that can deliver speed, accuracy and reproducibility can consume a significant amount of time and resources. The shift toward screening focused libraries against multiple targets in parallel can add to the assay development burden substantially.

In this webinar you will learn:

  • How a few different Transcreener HTS Assays allow robust, initial velocity detection of hundreds of chromatin modifying enzymes, including methyltransferases, acetyltransferases, kinases, glycosyltransferases, and SUMO ligases.
  • How to sync Transcreener assays with Tecan’s plate readers to generate high quality screening or profiling data.
  • How to eliminate costly biochemical assay development using turnkey kits combining Transcreener assays and pre-calibrated kinase and methyltransferase enzymes and substrates.

Participants should come away confident that they can apply a robust, cost-effective, user friendly solution to immediately begin screening or profiling chromatin modifying enzymes.

After registering, you will receive a confirmation email containing information about joining the webinar.

About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.

About Tecan. Tecan ( is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
2. BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases
3. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
4. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
5. Poliwogg’s Greg Simon Says Lifting of SEC Solicitation Ban for Private Offerings Will Vastly Expand Healthcare Investment
6. Vetter Offers a Sterile Water-for-injection Solution with 5 Years Stability Data
7. Cellular Dynamics International Announces Launch of Initial Public Offering
8. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
9. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
10. Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
11. St. Josephs Hospital is the First in Florida to Offer Non-invasive Test to Predict Stroke Risk
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ... Dr. Norman C.W. Wong to its Board of ... comes to Zenith with a wealth of experience as co-founder ... molecular biology. --> --> ... Zenith Epigenetics, board of directors. Zenith,s long standing expertise in ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
(Date:11/30/2015)... 2015  AbbVie, is introducing Good Morning Hypothyroidism ... daily routine for managing the life-long condition of hypothyroidism. ... the way the body absorbs it so resources encouraging ... routine are important. The goal of the new website ... their hypothyroidism by establishing a daily routine, spirit of ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 ... leading developer of adult stem cell technologies for neurodegenerative diseases, ... has been awarded an additional grant of approximately $735,000 from ... (OCS). This grant, the second this year, brings the total ... $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... Paris , qui ... Paris , qui s,est tenu du ... leader de l,innovation biométrique, a inventé le premier scanner ... sur la même surface de balayage. Jusqu,ici, deux scanners ... les empreintes digitales. Désormais, un seul scanner est en ...
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
Breaking Biology News(10 mins):